🔗 Share this article

Chancellor Rachel Reeves has revealed she is preparing "focused measures to deal with cost of living issues" in the upcoming Budget.

During an interview with the BBC, she emphasized that reducing price rises is a collective duty of both the administration and the Bank of England.

The UK's inflation rate is forecast to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Potential Energy Bill Measures

Sources suggest the government could take action to bring down energy bills, such as by slashing the current 5% rate of value-added tax charged on energy.

An additional approach is to cut some of the government charges presently added to bills.

Fiscal Constraints and Expert Predictions

The government will obtain the latest report from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much space there is for these measures.

The consensus from the majority of experts is that Reeves will have to announce tax rises or spending cuts in order to fulfill her declared borrowing rules.

Earlier on the same day, estimates showed there was a £22bn gap for the Treasury chief to resolve, which is at the more modest range of forecasts.

"It is a shared job between the Bank of England and the administration to further reduce some of the drivers of price increases," the Chancellor stated to the BBC in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.

Tax Pledges and International Concerns

While a great deal of the focus has been on probable tax rises, the chancellor said the most recent data from the OBR had not changed her vow to manifesto promises not to increase tax levels on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with increasing international and commercial issues for the fiscal tax moves, likely to be targeted on those "with the broadest shoulders."

Global Economic Tensions

Commenting on worries about the UK's trade ties with China she said: "The UK's security interests always are paramount."

Last week's declaration by Chinese authorities to strengthen export controls on critical minerals and other resources that are crucial for high-technology manufacturing led American leader Donald Trump to suggest an extra 100% import tax on goods from the Asian country, raising the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary labeled China's action "commercial pressure" and "a global supply chain power grab."

Inquired about considering the American proposal to join its battle with China, Reeves said she was "extremely troubled" by China's actions and urged the Chinese government "not to put up barriers and restrict access."

She said the decision was "harmful for the international commerce and creates further challenges."

"It is my opinion there are fields where we should confront China, but there are also important chances to export to Chinese markets, including banking sector and other sectors of the economic system. We've got to achieve that balance correct."

The chancellor also affirmed she was working with international partners "regarding our own essential resources plan, so that we are more independent."

Health Service Drug Costs and Funding

The Chancellor also acknowledged that the cost the National Health Service pays for medicines could increase as a consequence of current negotiations with the Trump administration and its drugs companies, in exchange for reduced taxes and capital.

Some of the biggest global drug companies have said lately that they are either pausing or canceling investments in the United Kingdom, with several attributing the low prices they are obtaining.

Recently, the Science Minister said the price the NHS spends on medicines would must rise to prevent firms and drug research funding leaving the UK.

The Chancellor informed the BBC: "We have seen because of the payment system, that medical research, new drugs have not been available in the United Kingdom in the way that they are in other continental states."

"The objective is to make sure that patients receiving care from the NHS are can receive the finest life-saving medicines in the world. And so we are reviewing these issues, and... aiming to attract increased funding into Britain."